Aoki Y - Search Results

1

High-risk group in node-positive patients with stage IB, IIA, and IIB cervical carcinoma after radical hysterectomy and postoperative pelvic irradiation.

Aoki Y, Sasaki M, Watanabe M, Sato T, Tsuneki I, Aida H, Tanaka K. Aoki Y, et al. Gynecol Oncol. 2000 May;77(2):305-9. doi: 10.1006/gyno.2000.5788. Gynecol Oncol. 2000. PMID: 10785483

2

Ovarian metastasis in stage IB and II cervical adenocarcinoma.

Natsume N, Aoki Y, Kase H, Kashima K, Sugaya S, Tanaka K. Natsume N, et al. Among authors: aoki y. Gynecol Oncol. 1999 Aug;74(2):255-8. doi: 10.1006/gyno.1999.5442. Gynecol Oncol. 1999. PMID: 10419741 Review.

3

Analysis of TH1 and TH2 cells by intracellular cytokine detection with flow cytometry in patients with ovarian cancer.

Aoki Y, Tsuneki I, Sasaki M, Watanabe M, Sato T, Aida H, Tanaka K. Aoki Y, et al. Gynecol Obstet Invest. 2000;50(3):207-11. doi: 10.1159/000010312. Gynecol Obstet Invest. 2000. PMID: 11014957

4

Ovarian function after radical hysterectomy with ovarian preservation for cervical cancer.

Ishii K, Aoki Y, Takakuwa K, Tanaka K. Ishii K, et al. Among authors: aoki y. J Reprod Med. 2001 Apr;46(4):347-52. J Reprod Med. 2001. PMID: 11354835

5

Neoadjuvant chemotherapy using low-dose consecutive intraarterial infusions of cisplatin combined with 5-fluorouracil for locally advanced cervical adenocarcinoma.

Aoki Y, Sato T, Watanabe M, Sasaki M, Tsuneki I, Tanaka K. Aoki Y, et al. Gynecol Oncol. 2001 Jun;81(3):496-9. doi: 10.1006/gyno.2001.6195. Gynecol Oncol. 2001. PMID: 11371145 Clinical Trial.

6

Prognostic factors and failure pattern in lymph node-negative stage IB and II cervical carcinoma treated with radical hysterectomy and postoperative irradiation.

Aoki Y, Watanabe M, Sasaki M, Sato T, Kase H, Aida H, Kurata H, Tanaka K. Aoki Y, et al. Gynecol Obstet Invest. 2001;52(1):13-7. doi: 10.1159/000052933. Gynecol Obstet Invest. 2001. PMID: 11549857

7

Stage III endometrial cancer: analysis of prognostic factors and failure patterns after adjuvant chemotherapy.

Aoki Y, Kase H, Watanabe M, Sato T, Kurata H, Tanaka K. Aoki Y, et al. Gynecol Oncol. 2001 Oct;83(1):1-5. doi: 10.1006/gyno.2001.6321. Gynecol Oncol. 2001. PMID: 11585406

8

Neoadjuvant chemotherapy for patients younger than 50 years with high-risk squamous cell carcinoma of the cervix.

Aoki Y, Tomita M, Sato T, Watanabe M, Kase H, Fujita K, Kurata H, Tanaka K. Aoki Y, et al. Gynecol Oncol. 2001 Nov;83(2):263-7. doi: 10.1006/gyno.2001.6371. Gynecol Oncol. 2001. PMID: 11606081 Clinical Trial.

9

Low risk endometrial cancer: a study of pelvic lymph node metastasis.

Watanabe M, Aoki Y, Kase H, Fujita K, Tanaka K. Watanabe M, et al. Among authors: aoki y. Int J Gynecol Cancer. 2003 Jan-Feb;13(1):38-41. doi: 10.1046/j.1525-1438.2003.13037.x. Int J Gynecol Cancer. 2003. PMID: 12631218

10

Failure of high-dose chemotherapy with peripheral blood stem cell support for refractory placental site trophoblastic tumor.

Aoki Y, Kodama S, Kurata H, Kase H, Tanaka K. Aoki Y, et al. Gynecol Obstet Invest. 1999;47(3):214-6. doi: 10.1159/000010081. Gynecol Obstet Invest. 1999. PMID: 10087421

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,562 results

Search Page

Filters